These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 22027757

  • 1. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
    Park KJ, Kwon EH, Ma Y, Park IA, Kim SW, Kim SH, Kim HJ.
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
    [Abstract] [Full Text] [Related]

  • 2. Low intraindividual variability of activated partial thromboplastin time revealed in a population of 10,487 control individuals.
    Ma Y, Huh HJ, Kim SH, Kim HJ.
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):746-8. PubMed ID: 24064902
    [Abstract] [Full Text] [Related]

  • 3. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A, Mischke R, Nolte I.
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [Abstract] [Full Text] [Related]

  • 4. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
    Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Barnes P, Cox JL, Lappas DG.
    Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
    [Abstract] [Full Text] [Related]

  • 5. Haemostatic reference intervals in pregnancy.
    Szecsi PB, Jørgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S.
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ, Zafer M, Nair SC, Hertzberg M, North K.
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [Abstract] [Full Text] [Related]

  • 7. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E, Böck M, Vrielink GJ, Liem R, Hendriks H, de Kieviet W.
    Thromb Res; 2007 Oct; 121(3):361-7. PubMed ID: 17568658
    [Abstract] [Full Text] [Related]

  • 8. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A, Smith J, Woolley AM, Kitchen S, Hampton KK, Maclean RM, VAN Veen JJ, Makris M.
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [Abstract] [Full Text] [Related]

  • 9. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ, Kershaw G, Mohammed S, Lippi G.
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [Abstract] [Full Text] [Related]

  • 10. Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters.
    Geens T, Vertessen F, Malfait R, Deiteren K, Maes MB.
    Int J Lab Hematol; 2015 Jun; 37(3):372-81. PubMed ID: 25233923
    [Abstract] [Full Text] [Related]

  • 11. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
    Clyne LP, Honig CL, Dainiak N.
    Thromb Haemost; 1984 Jul 29; 51(3):317-20. PubMed ID: 6437003
    [Abstract] [Full Text] [Related]

  • 12. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ, Sum C, Kuperan P.
    Singapore Med J; 2005 Sep 29; 46(9):450-6. PubMed ID: 16123828
    [Abstract] [Full Text] [Related]

  • 13. Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity.
    Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB.
    J Trauma; 2011 Nov 29; 71(5 Suppl 1):S435-40. PubMed ID: 22072000
    [Abstract] [Full Text] [Related]

  • 14. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH, Cowan JF, Khan M.
    J Lab Clin Med; 1977 Dec 29; 90(6):1054-65. PubMed ID: 303667
    [Abstract] [Full Text] [Related]

  • 15. Assessment of bleeding disorders in Sheehan's syndrome: are bleeding disorders the underlying cause of Sheehan's syndrome?
    Gokalp D, Tuzcu A, Bahceci M, Ayyildiz O, Erdemoglu M, Alpagat G.
    Platelets; 2011 Dec 29; 22(2):92-7. PubMed ID: 21133650
    [Abstract] [Full Text] [Related]

  • 16. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R, Jacobs C.
    Res Vet Sci; 2001 Apr 29; 70(2):101-8. PubMed ID: 11356088
    [Abstract] [Full Text] [Related]

  • 17. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
    McGlasson DL, Harroff HH, Sutton J, Dick E, Elston DM.
    Clin Lab Sci; 2007 Apr 29; 20(2):99-105. PubMed ID: 17557708
    [Abstract] [Full Text] [Related]

  • 18. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR, Stevenson KJ, Poller L.
    Thromb Haemost; 1984 Oct 31; 52(2):172-5. PubMed ID: 6441303
    [Abstract] [Full Text] [Related]

  • 19. Clotting changes in borderline hypertension.
    Patrassi GM, Fallo F, Santarossa A, Sartori MT, Casonato A, Girolami A.
    J Hum Hypertens; 1987 Sep 31; 1(2):101-3. PubMed ID: 3506621
    [Abstract] [Full Text] [Related]

  • 20. Activated partial thromboplastin time: new tricks for an old dogma.
    Lippi G, Favaloro EJ.
    Semin Thromb Hemost; 2008 Oct 31; 34(7):604-11. PubMed ID: 19085761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.